| - GRCh37:
- ChrMT:1606
- GRCh38:
- ChrMT:1606
| MT-TV | | Mitochondrial disease | Uncertain significance (Jun 30, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- ChrMT:1607
- GRCh38:
- ChrMT:1607
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1608
- GRCh38:
- ChrMT:1608
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1616
- GRCh38:
- ChrMT:1616
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Nov 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1617
- GRCh38:
- ChrMT:1617
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1618
- GRCh38:
- ChrMT:1618
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1619-1620
- GRCh38:
- ChrMT:1619-1620
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1619
- GRCh38:
- ChrMT:1619
| MT-TV | | not provided, Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Conflicting interpretations of pathogenicity (Jul 12, 2019) | criteria provided, conflicting interpretations |
| - GRCh37:
- ChrMT:1624
- GRCh38:
- ChrMT:1624
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Pathogenic/Likely pathogenic (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrMT:1628
- GRCh38:
- ChrMT:1628
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1629
- GRCh38:
- ChrMT:1629
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1630
- GRCh38:
- ChrMT:1630
| MT-TV | | Mitochondrial disease | Uncertain significance (Nov 14, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- ChrMT:1631
- GRCh38:
- ChrMT:1631
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1636
- GRCh38:
- ChrMT:1636
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1638
- GRCh38:
- ChrMT:1638
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1640
- GRCh38:
- ChrMT:1640
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1641
- GRCh38:
- ChrMT:1641
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1642
- GRCh38:
- ChrMT:1642
| MT-TV | | not specified | Uncertain significance (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1643
- GRCh38:
- ChrMT:1643
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1644
- GRCh38:
- ChrMT:1644
| MT-TV | | Mitochondrial disease | Likely pathogenic (Dec 10, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- ChrMT:1644
- GRCh38:
- ChrMT:1644
| MT-TV | | Leigh syndrome | not provided | no assertion provided |
| - GRCh37:
- ChrMT:1646
- GRCh38:
- ChrMT:1646
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1654
- GRCh38:
- ChrMT:1654
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1655
- GRCh38:
- ChrMT:1655
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1655
- GRCh38:
- ChrMT:1655
| MT-TV | | Epilepsy, Developmental delay, Hyperlactaemia, Axial hypotonia | Uncertain significance (Nov 21, 2016) | no assertion criteria provided |
| - GRCh37:
- ChrMT:1657-1658
- GRCh38:
- ChrMT:1657-1658
| MT-TV | | See cases | Uncertain significance (Jul 2, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1657
- GRCh38:
- ChrMT:1657
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1658
- GRCh38:
- ChrMT:1658
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1659
- GRCh38:
- ChrMT:1659
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Pathogenic/Likely pathogenic (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrMT:1661
- GRCh38:
- ChrMT:1661
| MT-TV | | not specified | Uncertain significance (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1664
- GRCh38:
- ChrMT:1664
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:1670
- GRCh38:
- ChrMT:1670
| MT-TV | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |